PETABYTE TECHNOLOGY, INC. – Trademark Portfolio
Entity Type: 03
PETABYTE TECHNOLOGY, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 8 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include BOOP, PETABYTE, RHAPSODY, and PETABYTE ANALYTICS. The owner is based in Westlake Village, CA.
310 N. Westlake Blvd., Suite 120
Westlake Village, CA 91362
Showing of trademarks Trademarks
Trademark Classifications
PETABYTE TECHNOLOGY, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does PETABYTE TECHNOLOGY, INC. have?
PETABYTE TECHNOLOGY, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 abandoned, 2 cancelled.
What trademark classes does PETABYTE TECHNOLOGY, INC. file in?
PETABYTE TECHNOLOGY, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are PETABYTE TECHNOLOGY, INC.'s most well-known trademarks?
PETABYTE TECHNOLOGY, INC.'s registered trademark portfolio includes well-known marks such as BOOP, PETABYTE, RHAPSODY, and PETABYTE ANALYTICS. These are among 7 currently registered trademarks in the portfolio.
What is PETABYTE TECHNOLOGY, INC.'s trademark registration success rate?
PETABYTE TECHNOLOGY, INC. has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.